From a clinical perspective, we found no significant co-occurrence of GASC1 and ROCK2 at mRNA levels in TCGA liver cancer samples (442 patients) from the cbioportal database (http://www.cbioportal.org)41 (Supplementary Fig. 5f). The gene discussed is ROCK2; the disease is liver cancer.